S. Leclercq

发表

Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety

C. Bombardier, O. Schieir, M. Gardam, 2012, The Journal of Rheumatology.

Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

C. Bombardier, O. Schieir, V. Bykerk, 2012, The Journal of Rheumatology.

Rapid responses to anakinra in patients with refractory adult-onset Still's disease.

C. Dinarello, S. Leclercq, J. Homik, 2005, Arthritis and rheumatism.

The development of systemic sclerosis classification criteria

M. Hudson, S. Taillefer, M. Baron, 2007, Clinical Rheumatology.

Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.

M. Hudson, M. Baron, Mianbo Wang, 2016, Rheumatology.

Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma

M. Mayes, S. Heimfeld, K. Sullivan, 2018, The New England journal of medicine.

Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

G. Jhangri, S. Leclercq, W. Maksymowych, 2001, The Journal of rheumatology.

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

M. Hudson, S. Taillefer, M. Baron, 2007, Clinical Rheumatology.

Assessment of reproductive history in systemic sclerosis.

M. Hudson, M. Baron, S. Bernatsky, 2008, Arthritis and rheumatism.

Ankylosing spondylitis in families with two distinct B27 haplotypes: a selective association.

M. Suarez‐Almazor, S. Leclercq, A. Russell, 1986, Arthritis and rheumatism.

Ankylosing spondylitis: a family study.

S. Leclercq, A. Russell, L. Chaput, 1983, The Journal of rheumatology.

2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Outperform the 1980 Criteria: Data From the Canadian Scleroderma Research Group

M. Hudson, M. Baron, M. Fritzler, 2015, Arthritis care & research.

Autologous hematopoietic cell transplantation for systemic sclerosis — a challenge for the Canadian health care system

S. Leclercq, J. Storek, A. Daly, 2017, Canadian Medical Association Journal.

Anti-RANA antibody in rheumatoid arthritis, seronegative polyarthritis, and normal controls

S. Leclercq, P. Davis, 1982, Rheumatology International.

The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation.

C. Barnabe, S. Leclercq, A. Fitzgerald, 2009, Seminars in arthritis and rheumatism.

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

G. Jhangri, S. Leclercq, J. Homik, 2002, Arthritis and rheumatism.

An open study of pamidronate in the treatment of refractory ankylosing spondylitis.

G. Jhangri, S. Leclercq, W. Maksymowych, 1998, The Journal of rheumatology.

Demographic and Clinical Factors Associated with Physician Service Use in Systemic Sclerosis

M. Hudson, M. Baron, S. Bernatsky, 2008, The Journal of Rheumatology.

Genetic markers for acute anterior uveitis.

S. Leclercq, A. Russell, J. Percy, 1983, The Journal of rheumatology.

Clinical examination of the sacroiliac joints: a prospective study.

S. Leclercq, W. Maksymowych, A. S. Russel, 1981, Arthritis and rheumatism.

Non-biologic disease-modifying antirheumatic drugs (DMARDs) improve pain in inflammatory arthritis (IA): a systematic literature review of randomized controlled trials

V. Bykerk, J. Pope, C. Barnabe, 2013, Rheumatology International.

T cells expressing delayed‐type hypersensitivity can be derived from a humorally immune lymphocyte population

S. Leclercq, Peter A. Bretscher, 1987, European journal of immunology.

The cost of systemic sclerosis.

M. Hudson, M. Baron, S. Bernatsky, 2008, Arthritis and rheumatism.

Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials

Jacob Karsh, Daniel J Clauw, S. Jamal, 2016, Arthritis care & research.

The relationship of dyspnoea to function and quality of life in systemic sclerosis

B. Thombs, M. Hudson, M. Baron, 2007, Annals of the rheumatic diseases.

Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial

M. Mayes, K. Sullivan, D. Furst, 2013, The Journal of Rheumatology.

Sex Differences in Pain Scores and Localization in Inflammatory Arthritis: A Systematic Review and Metaanalysis

V. Bykerk, J. Pope, C. Barnabe, 2012, The Journal of Rheumatology.

Healthcare resource utilization and costs in stable patients with rheumatoid arthritis: Comparing nurse-led and rheumatologist-led models of care delivery.

T. Noseworthy, S. Leclercq, D. Mosher, 2022, Seminars in arthritis and rheumatism.

Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints

S. Jamal, M. Fitzcharles, J. Karsh, 2014, BMC Musculoskeletal Disorders.

Radiologic features of DISH may mimic ankylosing spondylitis.

S. Leclercq, A. Russell, C. Ramos-Remus, 1993, Clinical and experimental rheumatology.

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.

G. Raghu, M. Scholand, J. Albayda, 2022, The Lancet. Respiratory medicine.

Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs

C. Bombardier, O. Schieir, V. Bykerk, 2012, The Journal of Rheumatology.

Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?

V. Bykerk, S. Edworthy, S. Leclercq, 2008, The Journal of rheumatology.